Belsar 40 mg (Tablet)
Unit Price: ৳ 18.00 (4 x 7: ৳ 504.00)
Strip Price: ৳ 126.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Olmesartan medoxomil |
| Company | Beacon pharmaceuticals plc |
| Also available as |
Title
- Belsar 40 mg Tablet
Categories
- Hypertension Medication
- Antihypertensive Agent
- Angiotensin II Receptor Blocker
Description
- Olmesartan is indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents.
- Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT 1 receptor in vascular smooth muscle.
- The recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted.
- No initial dosage adjustment is recommended for elderly patients or for patients with marked renal impairment.
- Belsar has been evaluated for safety in more than 3825 patients/subjects, with an incidence of adverse reactions similar to placebo.
- When pregnancy is detected, discontinue this product as soon as possible.
- Changes in renal function may be anticipated in susceptible individuals treated with Belsar.
DosageAndAdministration
- Individualized dosage
- Usual starting dose of 20 mg once daily
- Potential for lower starting dose in certain patients
- Paediatric use safety and effectiveness not established
Interaction
- No significant drug interactions reported in studies with digoxin or warfarin
- Bioavailability not significantly altered by antacids
- No effects on cytochrome P450 system
- Caution with NSAIDs and selective COX-2 inhibitors due to potential deterioration of renal function
Contraindications
- Hypersensitivity to any component of this product
SideEffects
- Well tolerated with similar incidence of adverse reactions to placebo
- Common adverse reactions include dizziness, back pain, diarrhea, headache, and cough
PregnancyAndLactation
- Discontinue if pregnancy is detected
- Potential excretion in human milk
- Consideration of adverse effects on nursing infant
PrecautionsAndWarnings
- Potential changes in renal function
- Association with oliguria, progressive azotemia, and acute renal failure in susceptible individuals
OverdoseEffects
- No experience of overdose reported
- Possible effects include hypotension and tachycardia
- Clinical support and monitoring recommended for significant hypotension
TherapeuticClass
- Angiotensin-ll receptor blocker
StorageConditions
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of the reach of children
ChemicalStructure
- Molecular Formula: C29H30N6O6
CommonQuestions
- Average time for peak effect is 1 day to 1 week
- Usual frequency of once or twice a day
- Oral consumption advised
- Storage at room temperature away from heat and direct light
- Quick tips for usage including regular intake time, potential dizziness, regular tests, and avoiding certain medicines
AdditionalInformation
- Angiotensin II is the principal pressor agent of the renin-angiotensin system
- Twice-daily dosing offers no advantage over once daily dosing
- No initial dosage adjustment recommended for elderly patients or those with marked renal impairment or marked hepatic dysfunction
- Storage temperature below 30°C and protection from light and moisture
ChemicalStructureImageURL
- https://medex.com.bd/storage/res/g-res-822-olmesartan-medoxomil-chemical-structure-XdunPf7zhrREoTiawNhA.png